M28 Capital Management LP Long-Term Concentrated

CIK: 0001807489 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 13, 2022

Total Value ($000): $108,762 (100.0% shares, 0.0% debt)

Holdings (13)

IVVD ADAGIO THERAPEUTICS INC 26.8%

Value ($000) $29,176 Shares 6,398,250 Est. Cost $23.72 Unrealized -74.2%

WVE WAVE LIFE SCIENCES LTD 10.8%

Value ($000) $11,700 Shares 5,850,000 Est. Cost $3.55 Unrealized -30.9%

RCKT ROCKET PHARMACEUTICALS INC 10.4%

Value ($000) $11,354 Shares 715,880 Est. Cost $24.20 Unrealized -28.6%

STOK STOKE THERAPEUTICS INC 10.2%

Value ($000) $11,097 Shares 527,150 Est. Cost $23.86 Unrealized -16.1%

— CURIS INC 9.3%

Value ($000) $10,099 Shares 4,243,293 Est. Cost $3.84 Unrealized —

TGTX TG THERAPEUTICS INC 9.2%

Value ($000) $9,966 Shares 1,047,900 Est. Cost $18.81 Unrealized -38.5%

— MIRATI THERAPEUTICS INC 6.3%

Value ($000) $6,816 Shares 82,900 Est. Cost $97.15 Unrealized —

BBIO BRIDGEBIO PHARMA INC 4.4%

Value ($000) $4,732 Shares 466,200 Est. Cost $42.31 Unrealized -75.7%

— LEAP THERAPEUTICS INC 4.3%

Value ($000) $4,663 Shares 2,664,400 Est. Cost $2.31 Unrealized —

— VERVE THERAPEUTICS INC 3.7%

Value ($000) $4,073 Shares 178,500 Est. Cost $22.82 Unrealized —

— ATARA BIOTHERAPEUTICS INC 3.3%

Value ($000) $3,617 Shares 389,353 Est. Cost $15.76 Unrealized —

PRQR PROQR THERAPEUTICS N V 0.8%

Value ($000) $907 Shares 1,001,800 Est. Cost $3.35 Unrealized 0.0%

— NEXIMMUNE INC 0.5%

Value ($000) $562 Shares 133,442 Est. Cost $4.61 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IVVD	ADAGIO THERAPEUTICS INC	6,398,250	$29,176	26.8%	$23.72	-74.2%	COM	00534A102
WVE	WAVE LIFE SCIENCES LTD	5,850,000	$11,700	10.8%	$3.55	-30.9%	SHS	Y95308105
RCKT	ROCKET PHARMACEUTICALS INC	715,880	$11,354	10.4%	$24.20	-28.6%	COM	77313F106
STOK	STOKE THERAPEUTICS INC	527,150	$11,097	10.2%	$23.86	-16.1%	COM	86150R107
—	CURIS INC	4,243,293	$10,099	9.3%	$3.84	—	COM NEW	231269200
TGTX	TG THERAPEUTICS INC	1,047,900	$9,966	9.2%	$18.81	-38.5%	COM	88322Q108
—	MIRATI THERAPEUTICS INC	82,900	$6,816	6.3%	$97.15	—	COM	60468T105
BBIO	BRIDGEBIO PHARMA INC	466,200	$4,732	4.4%	$42.31	-75.7%	COM	10806X102
—	LEAP THERAPEUTICS INC	2,664,400	$4,663	4.3%	$2.31	—	COM	52187K101
—	VERVE THERAPEUTICS INC	178,500	$4,073	3.7%	$22.82	—	COM	92539P101
—	ATARA BIOTHERAPEUTICS INC	389,353	$3,617	3.3%	$15.76	—	COM	046513107
PRQR	PROQR THERAPEUTICS N V	1,001,800	$907	0.8%	$3.35	0.0%	SHS EURO	N71542109
—	NEXIMMUNE INC	133,442	$562	0.5%	$4.61	—	COM	65344D109